We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 21-40 of 10,000 results
  1. Fasting in combination with the cocktail Sorafenib:Metformin blunts cellular plasticity and promotes liver cancer cell death via poly-metabolic exhaustion

    Purpose

    Dual-Interventions targeting glucose and oxidative metabolism are receiving increasing attention in cancer therapy. Sorafenib (S) and...

    Juan L. López-Cánovas, Beatriz Naranjo-Martínez, Alberto Diaz-Ruiz in Cellular Oncology
    Article Open access 11 July 2024
  2. ESRP1-mediated biogenesis of circPTPN12 inhibits hepatocellular carcinoma progression by PDLIM2/ NF-κB pathway

    Background

    Emerging evidence indicates the pivotal involvement of circular RNAs (circRNAs) in cancer initiation and progression. Understanding the...

    Yang Ji, Chuangye Ni, ... Xuehao Wang in Molecular Cancer
    Article Open access 11 July 2024
  3. N6-methyladenosine modification of circMARK2 enhances cytoplasmic export and stabilizes LIN28B, contributing to the progression of Wilms tumor

    Background

    The potential involvement of circular RNAs (circRNAs) and N 6 -methyladenosine (m 6 A) modification in the progression of Wilms tumor (WT) has...

    Guannan Shu, Zhang Zhao, ... Guochang Liu in Journal of Experimental & Clinical Cancer Research
    Article Open access 11 July 2024
  4. Impact of baseline body composition on prognostic outcomes in urological malignancies treated with immunotherapy: a pooled analysis of 10 retrospective studies

    Objective

    Numerous epidemiological investigations have explored the impact of body composition on the effectiveness of immune checkpoint inhibitors...

    Wangbin Ma, Qiao Shi, ... ZK in BMC Cancer
    Article Open access 11 July 2024
  5. Survival of advanced/recurrent gastrointestinal stromal tumors treated with tyrosine kinase inhibitors in Taiwan: a nationwide registry study

    Background

    Most gastrointestinal stromal tumors (GISTs) harbor c-KIT or PDGFRA mutations. Administration of tyrosine kinase inhibitors (TKIs) has...

    Hui-Jen Tsai, Yan-Shen Shan, ... Tsang-En Wang in BMC Cancer
    Article Open access 11 July 2024
  6. The relationship between Stroma AReactive Invasion Front Areas (SARIFA), Warburg-subtype and survival: results from a large prospective series of colorectal cancer patients

    Background

    Stroma AReactive Invasion Front Areas (SARIFA) is a recently identified haematoxylin & eosin (H&E)based histopathologic biomarker in...

    Kelly Offermans, Nic G. Reitsam, ... Piet A. van den Brandt in Cancer & Metabolism
    Article Open access 11 July 2024
  7. A new approach to prevent radiation-induced xerostomia using intraglandular injection of mitochondria-boosting agents

    Radiotherapy in patients with head and neck cancer fairly leads to xerostomia, profoundly affecting their quality of life. With limited effective...

    Mohammad Farhadi, Pedram Fadavi, ... Farzad Taghizadeh-Hesary in BMC Cancer
    Article Open access 11 July 2024
  8. Circ_0000069 promotes the development of hepatocellular carcinoma by regulating CCL25

    Background

    Hepatocellular carcinoma (HCC) is a leading cause of cancer-related deaths globally, influenced by aberrant circRNA expression....

    Junshao Zeng, Yi Feng, ... Yifan Sun in BMC Cancer
    Article Open access 11 July 2024
  9. Understanding the experience, treatment preferences and goals of people living with chronic lymphocytic leukemia (CLL) in Australia

    Background

    Listening to patient voices is critical, in terms of how people experience their condition as well as their treatment preferences. This...

    Simon Fifer, Jenni Godsell, ... Marija McGeachie in BMC Cancer
    Article Open access 11 July 2024
  10. Combination of dual JAK/HDAC inhibitor with regorafenib synergistically reduces tumor growth, metastasis, and regorafenib-induced toxicity in colorectal cancer

    Background

    Treatment with regorafenib, a multiple-kinase inhibitor, to manage metastatic colorectal cancers (mCRCs) shows a modest improvement in...

    Prachi Bajpai, Sumit Agarwal, ... Upender Manne in Journal of Experimental & Clinical Cancer Research
    Article Open access 11 July 2024
  11. Combinatorial macrophage induced innate immunotherapy against Ewing sarcoma: Turning “Two Keys” simultaneously

    Background

    Macrophages play important roles in phagocytosing tumor cells. However, tumors escape macrophage phagocytosis in part through the...

    Wen Luo, Hai Hoang, ... Mitchell S. Cairo in Journal of Experimental & Clinical Cancer Research
    Article Open access 11 July 2024
  12. The black box of the relationship between breast cancer patients and accompanying patients: the accompanied patients’ point of view

    Background

    The PAROLE-Onco program was introduced in the province of Quebec, Canada in 2019. It integrates accompanying patients (APs), i.e., people...

    Marie-Pascale Pomey, Monica Iliescu Nelea, ... Michèle de Guise in BMC Cancer
    Article Open access 10 July 2024
  13. Associations between modifiable risk factors and hepatocellular carcinoma: a trans-ancestry Mendelian randomization study

    Background

    Potentially modifiable risk factors for hepatocellular carcinoma (HCC) have been investigated in observational epidemiology studies in East...

    **aoxia Wei, Chenglei Yang, ... Yingchun Liu in BMC Cancer
    Article Open access 10 July 2024
  14. miRNAs: possible regulators of toll like receptors and inflammatory tumor microenvironment in colorectal cancer

    Background

    Colorectal cancer (CRC) is ranked as the third most commonly diagnosed cancer and the third cause of cancer related deaths. CRC is greatly...

    Marwa Matboli, Nourhan Hossam, ... Sanaa Eissa in BMC Cancer
    Article Open access 10 July 2024
  15. Influence of cryoablation versus operation on circulating lymphocyte subsets in patients with early-stage renal cell carcinoma

    Immune response is known to play an important role in local tumor control especially in renal cell carcinoma (RCC), which is considered highly...

    Johanna Waidhauser, Anna-Katharina Gantner, ... Thomas Kröncke in BMC Cancer
    Article Open access 10 July 2024
  16. Immune dysfunction prior to and during vaccination in multiple myeloma: a case study based on COVID-19

    Infection is the leading cause of death in multiple myeloma (MM). However, the cellular composition associated with immune dysfunction is not...

    Esperanza Martín-Sánchez, Luis-Esteban Tamariz-Amador, ... Jesus F. San Miguel in Blood Cancer Journal
    Article Open access 10 July 2024
  17. Systemic therapy and radiotherapy related complications and subsequent hospitalisation rates: a systematic review

    Background

    Hospitalisation  resulting from complications of systemic therapy and radiotherapy places a substantial burden on the patient, society, and...

    Rashidul Alam Mahumud, Md. Shahjalal, ... Olivia Wawryk in BMC Cancer
    Article Open access 10 July 2024
  18. Establishment of a trastuzumab-resistant extramammary Paget disease model: loss of PTEN as a potential mechanism

    Background/objectives

    Extramammary Paget disease (EMPD) is a rare, cutaneous intraepithelial adenocarcinoma typically treated with wide local...

    Che-Yuan Hsu, Teruki Yanagi, ... Hideyuki Ujiie in British Journal of Cancer
    Article 10 July 2024
Did you find what you were looking for? Share feedback.